Company intelligence / Profile preview

Bax Pharma

Ownership: Private
Development stage: Commercial

Overview

Bax Pharma is an active specialty pharmaceutical and medical device distribution company based in Slovakia. It was established in 1998 as an exclusive distributor for Baxter IV solutions and has since expanded to distribute drugs, medical devices, diagnostics, and drug tests from major global companies. The company's main customers are hospitals, specialized treatment centers, dialysis centers, and home care patients.

Modalities: Small molecule (as a drug distributor)Biologic (as a drug distributor)
Industry: Non-Academic Healthcare

Drug pipeline

2 assets

entyvio

Commercial

Indications: Gastroenterology

1 more asset in the full pipeline.

Request access →

Partnerships

Baxter InternationalTakeda/ShireMedtronic/CovidienRoche DiagnosticsB. Braun

Beyond the preview

Go deeper on Bax Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bax Pharma.

Explore the full profile